• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives Isoquinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives

Comprehensive Analysis of 7-Fluoroisoquinoline-1-carbonitrile (CAS No. 1427501-79-8): Properties, Applications, and Industry Insights

In the rapidly evolving field of pharmaceutical and agrochemical research, 7-Fluoroisoquinoline-1-carbonitrile (CAS No. 1427501-79-8) has emerged as a compound of significant interest. This heterocyclic organic molecule, characterized by its fluorine substitution and nitrile functional group, offers unique reactivity and versatility. Its molecular structure, C₁₀H₅FN₂, combines the isoquinoline backbone with strategic modifications, making it a valuable intermediate in synthetic chemistry.

The growing demand for fluorinated compounds in drug discovery has propelled 7-Fluoroisoquinoline-1-carbonitrile into the spotlight. Researchers are particularly intrigued by its potential as a building block for kinase inhibitors and central nervous system (CNS) targeting agents, aligning with trends in precision medicine. Recent studies highlight its role in modulating protein-protein interactions, a hot topic in cancer therapeutics and neurodegenerative disease research.

From a synthetic chemistry perspective, the electron-withdrawing effects of both the fluorine atom and cyano group create distinct reactivity patterns. This enables selective functionalization at multiple positions, addressing the pharmaceutical industry's need for structure-activity relationship (SAR) optimization. The compound's lipophilicity (calculated LogP ≈ 2.1) and hydrogen bond acceptor capacity make it particularly relevant for blood-brain barrier penetration studies.

Environmental and regulatory considerations are shaping modern chemical development, and 7-Fluoroisoquinoline-1-carbonitrile presents advantages in this regard. Its molecular efficiency (MW: 172.16 g/mol) aligns with green chemistry principles, minimizing waste generation. The fluorine atom's strategic placement enhances metabolic stability - a key concern in drug design - potentially reducing dosage requirements and environmental burden.

Analytical characterization of this compound reveals distinctive spectral features. The 19F NMR signal typically appears around -110 ppm (referenced to CFCl₃), while the nitrile stretching vibration in IR spectroscopy is observed near 2230 cm^-1. These markers facilitate quality control during scale-up processes, a critical consideration for contract manufacturing organizations (CMOs).

Emerging applications in material science are expanding the utility of 7-Fluoroisoquinoline-1-carbonitrile beyond life sciences. Its planar aromatic structure and dipole moment (estimated at 3.2 D) make it a candidate for organic electronic materials, particularly in OLED development and molecular sensors. This dual applicability in pharmaceuticals and advanced materials represents a compelling value proposition for specialty chemical suppliers.

The global market for fluorinated heterocycles is projected to grow at 6.8% CAGR through 2030, with 7-Fluoroisoquinoline-1-carbonitrile positioned as a niche but high-value segment. Supply chain resilience has become paramount post-pandemic, driving innovation in continuous flow synthesis methods for such intermediates. Recent patent analyses show increasing protection around derivative compounds, indicating rising commercial interest.

From a safety standpoint, proper handling of 7-Fluoroisoquinoline-1-carbonitrile requires standard laboratory precautions for nitrile-containing compounds. The material's stability profile allows for storage under nitrogen at ambient temperature, facilitating logistics in global distribution networks. These practical considerations contribute to its adoption in parallel synthesis platforms and combinatorial chemistry applications.

Future research directions likely include exploration of asymmetric synthesis routes to access enantiomerically pure derivatives, as chirality becomes increasingly important in targeted drug delivery. The compound's potential in proteolysis targeting chimera (PROTAC) development also warrants investigation, given the pharmaceutical industry's focus on this revolutionary modality.

In conclusion, 7-Fluoroisoquinoline-1-carbonitrile (CAS No. 1427501-79-8) exemplifies the convergence of structural elegance and functional utility in modern chemical research. Its multifaceted applications across therapeutic development, material science, and synthetic methodology ensure its continued relevance in addressing complex scientific challenges. As innovation in fluorine chemistry advances, this compound will undoubtedly remain at the forefront of interdisciplinary research efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)